As of 4:00pm ET
| -0.35 / -3.32%|
The 7 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 24.00, with a high estimate of 28.00 and a low estimate of 15.00. The median estimate represents a +135.29% increase from the last price of 10.20.
The current consensus among 8 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.